{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:34:00Z","timestamp":1770842040268,"version":"3.50.1"},"reference-count":20,"publisher":"The Pediatric Pharmacy Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:p>This case report describes an extremely low birth weight infant, born at 26-week gestational age, who developed hypertrophic cardiomyopathy (HCM) and cardiogenic shock a few hours after administration of a small dose of dexamethasone. Although cases of steroid-induced cardiomyopathy in preterm neonates are known in literature, their adverse effects are insidious and are transient in occurrence. This is the first report of HCM and cardiogenic shock occurring acutely after administration of small-dose dexamethasone. This neonate received small-dose dexamethasone initially to prevent reintubation, and again to facilitate successful extubation. Both occurrences were associated with acute cardiac decompensation with reduction in ejection fraction within hours of administration. Cardiac function subsequently improved with discontinuation of drug and use of inotropic pharmacotherapy. Studies outlined in this report show that steroid-induced HCM is known and not isolated to dexamethasone alone; however, little is known on the adverse effect of small-dose steroid in resulting acute cardiac decompensation. This case is of educational value in clinical practice by highlighting the potential adverse effects even at the smaller doses of dexamethasone currently recommended in extremely low birth weight infants.<\/jats:p>","DOI":"10.5863\/1551-6776-27.8.760","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T18:21:40Z","timestamp":1668709300000},"page":"760-764","source":"Crossref","is-referenced-by-count":3,"title":["Preterm Neonate With Dexamethasone-Induced Acute Hypertrophic Cardiomyopathy and Cardiogenic Shock"],"prefix":"10.5863","volume":"27","author":[{"given":"Sherry","family":"Luedtke","sequence":"first","affiliation":[{"name":"Department of Pharmacy (SL), Texas Tech University Health Sciences Center at Amarillo, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusola A.","family":"Tijani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (OAT, JMA), Texas Tech University Health Sciences Center at Amarillo, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenda M.","family":"Arawiran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (OAT, JMA), Texas Tech University Health Sciences Center at Amarillo, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"10","key":"2022111718184450700_i2331-348X-27-8-760-b1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/00912700122012670","article-title":"Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial","volume":"41","author":"Zecca","year":"2001","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2022111718184450700_i2331-348X-27-8-760-b2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0022-3476(05)80446-9","article-title":"Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia","volume":"120","author":"Werner","year":"1992","journal-title":"J Pediatr"},{"issue":"1","key":"2022111718184450700_i2331-348X-27-8-760-b3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0002-8703(93)90089-R","article-title":"Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia","volume":"125","author":"Ohning","year":"1993","journal-title":"Am Heart J"},{"issue":"2","key":"2022111718184450700_i2331-348X-27-8-760-b4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00445591","article-title":"Cardiac hypertrophy secondary to ACTH treatment in children","volume":"142","author":"Lang","year":"1984","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2022111718184450700_i2331-348X-27-8-760-b5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/jp.2013.171","article-title":"Hypertrophic intraventricular flow obstruction after very-low-dose dexamethasone (Minidex) in preterm infants: case presentation and review of the literature","volume":"34","author":"Paech","year":"2014","journal-title":"J Perinatol"},{"issue":"2","key":"2022111718184450700_i2331-348X-27-8-760-b6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"2022111718184450700_i2331-348X-27-8-760-b7","first-page":"CD001146","article-title":"Early (&lt; 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","volume":"5","author":"Doyle","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2022111718184450700_i2331-348X-27-8-760-b8","first-page":"CD001144","article-title":"Moderately early (7\u201314 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","volume":"1","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2022111718184450700_i2331-348X-27-8-760-b9","doi-asserted-by":"crossref","first-page":"e206826","DOI":"10.1001\/jamapediatrics.2020.6826","article-title":"Assessment of postnatal corticosteroids for the prevention of bronchopulmonary dysplasia in preterm neonates: a systematic review and network meta-analysis","volume":"175","author":"Ramaswamy","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2022111718184450700_i2331-348X-27-8-760-b10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pedneo.2013.03.015","article-title":"Hypertrophic cardiomyopathy after a single dose of dexamethasone in a preterm infant","volume":"56","author":"Kale","year":"2015","journal-title":"Pediatr Neonatol"},{"issue":"4","key":"2022111718184450700_i2331-348X-27-8-760-b11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-994472","article-title":"Reversible steroid induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns","volume":"12","author":"Haney","year":"1995","journal-title":"Am J Perinatol"},{"issue":"2","key":"2022111718184450700_i2331-348X-27-8-760-b12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0929-693X(97)86160-X","article-title":"Myocardiopathie hypertrophique induite par les glucocorticoids chez le premature: a propos de quatre cas","volume":"4","author":"Boeuf","year":"1997","journal-title":"Arch Pediatr"},{"issue":"1","key":"2022111718184450700_i2331-348X-27-8-760-b13","first-page":"38","article-title":"Effect of beta-blockade on symptomatic dexamethasone induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and review of the literature","volume":"18","author":"Fritz","year":"1998","journal-title":"J Perinatol"},{"key":"2022111718184450700_i2331-348X-27-8-760-b14","first-page":"1","article-title":"Steroid induced hypertrophic cardiomyopathy","author":"Kumar","year":"2010","journal-title":"Asian Pac J Cardiol"},{"issue":"33","key":"2022111718184450700_i2331-348X-27-8-760-b15","doi-asserted-by":"crossref","first-page":"e16838","DOI":"10.1097\/MD.0000000000016838","article-title":"Transient hypertrophic cardiomyopathy and hypertension associated with hydrocortisone in preterm infant","volume":"98","author":"Jian","year":"2019","journal-title":"Medicine"},{"issue":"10","key":"2022111718184450700_i2331-348X-27-8-760-b16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/apa.12338","article-title":"Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single centre experience","volume":"102","author":"Rohr","year":"2013","journal-title":"Acta Paediatr"},{"issue":"5","key":"2022111718184450700_i2331-348X-27-8-760-b17","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1542\/peds.2006-0055","article-title":"Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia","volume":"117","author":"Dani","year":"2006","journal-title":"Pediatrics"},{"issue":"8","key":"2022111718184450700_i2331-348X-27-8-760-b18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1006\/jmcc.1999.0990","article-title":"Dexamethasone induce hypertrophy in rat neonatal cardiac myocytes involved and elevated L-type Ca (2+) current","volume":"31","author":"Whitehurst","year":"1999","journal-title":"J Mol Cell Cardiol"},{"issue":"13","key":"2022111718184450700_i2331-348X-27-8-760-b19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/01.CIR.0000160352.58142.06","article-title":"Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response","volume":"111","author":"Aoyama","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"2022111718184450700_i2331-348X-27-8-760-b20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1007128300430","article-title":"Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription","volume":"209","author":"Muangmingsuk","year":"2000","journal-title":"Mol Cell Biochem"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/27\/8\/760\/3147328\/i2331-348x-27-8-760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/27\/8\/760\/3147328\/i2331-348x-27-8-760.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:33:28Z","timestamp":1738780408000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/8\/article-p760.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-27.8.760","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}